ECG monitor from Finland secures FDA clearance

The U.S. Food and Drug Administration has cleared Mega Electronics' eMotion ECG monitor to work with Android-based smartphones, Mass Device reported. The Finnish company's device provides real-time remote heart rhythm monitoring that collects data and provides caregivers with alarms when abnormal heart rhythms are detected.

The eMotion ECG monitor leverages wireless electrodes that communicate via Bluetooth with a smartphone app. In addition, a GPS system can alert emergency services of a patient's location in case of emergency and the software has the flexibility to incorporate Bluetooth-based blood pressure and weight monitoring, according to the Mega Electronics website.

The company faces stiff competition from AliveCor and its smartphone ECG monitor, which is available on Apple iPhones and, as of October, on Android smartphones as well. However, unlike the eMotion system, AliveCor's device is not designed for continuous monitoring. Still, both devices must be prescribed by a physician. Article

Suggested Articles

The newly launched Center for Connected Health will be largest telehealth hub in the Philadelphia region, according to Penn Medicine.

The FDA commissioner wants to use additional funding under Trump's budget to advance digital health initiatives and integrate real-world data.

The FDA's approval of an app that uses AI to notify specialists of a potential stroke offers new possibilities for triage software that uses CDS.